Suppr超能文献

源自吡咯-2-羧酸硫酯的钌(II)二元化合物的合成及光生物活性

Synthesis and Photobiological Activity of Ru(II) Dyads Derived from Pyrrole-2-carboxylate Thionoesters.

作者信息

Smithen Deborah A, Yin Huimin, Beh Michael H R, Hetu Marc, Cameron T Stanley, McFarland Sherri A, Thompson Alison

机构信息

Department of Chemistry, Dalhousie University , P.O. Box 15000, Halifax, Nova Scotia B3H 4R2, Canada.

Department of Chemistry, Acadia University , 6 University Avenue, Wolfville, Nova Scotia B4P 2R6, Canada.

出版信息

Inorg Chem. 2017 Apr 3;56(7):4121-4132. doi: 10.1021/acs.inorgchem.7b00072. Epub 2017 Mar 16.

Abstract

The synthesis and characterization of a series of heteroleptic ruthenium(II) dyads derived from pyrrole-2-carboxylate thionoesters are reported. Ligands bearing a conjugated thiocarbonyl group were found to be more reactive toward Ru(II) complexation compared to analogous all-oxygen pyrrole-2-carboxylate esters, and salient features of the resulting complexes were determined using X-ray crystallography, electronic absorption, and NMR spectroscopy. Selected complexes were evaluated for their potential in photobiological applications, whereupon all compounds demonstrated in vitro photodynamic therapy effects in HL-60 and SK-MEL-28 cells, with low nanomolar activities observed, and exhibited some of the largest photocytotoxicity indices to date (>2000). Importantly, the Ru(II) dyads could be activated by relatively soft doses of visible (100 J cm, 29 mW cm) or red light (100 J cm, 34 mW cm), which is compatible with therapeutic applications. Some compounds even demonstrated up to five-fold selectivity for malignant cells over noncancerous cells. These complexes were also shown to photocleave, and in some cases unwind, DNA in cell-free experiments. Thus, this new class of Ru(II) dyads has the capacity to interact with and damage biological macromolecules in the cell, making them attractive agents for photodynamic therapy.

摘要

报道了一系列由吡咯 - 2 - 羧酸硫酯衍生的杂配钌(II)二元化合物的合成与表征。与类似的全氧吡咯 - 2 - 羧酸酯相比,带有共轭硫羰基的配体对Ru(II)络合更具反应性,并使用X射线晶体学、电子吸收光谱和核磁共振光谱确定了所得配合物的显著特征。对选定的配合物进行了光生物学应用潜力评估,结果所有化合物在HL - 60和SK - MEL - 28细胞中均表现出体外光动力治疗效果,观察到低纳摩尔活性,并且展现出一些迄今为止最大的光细胞毒性指数(>2000)。重要的是,Ru(II)二元化合物可以被相对低剂量的可见光(100 J/cm²,29 mW/cm²)或红光(100 J/cm²,34 mW/cm²)激活,这与治疗应用相兼容。一些化合物甚至对恶性细胞与非癌细胞表现出高达五倍的选择性。在无细胞实验中,这些配合物还显示出可光裂解DNA,在某些情况下可使DNA解旋。因此,这类新型Ru(II)二元化合物有能力与细胞中的生物大分子相互作用并对其造成损伤,使其成为光动力治疗的有吸引力的药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验